Complement Inhibition in Rare Kidney Disease: Response Heterogeneity and Biomarker-Guided Withdrawal. Translational Medicine & Therapeutics Journal, [S. l.], v. 4, n. 1, p. 28–36, 2025. DOI: 10.5281/zenodo.22649336. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/106. Acesso em: 5 nov. 2026.